This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The findings highlight that there remain communication gaps between oncology providers and patients and that opportunities exist for pharmacists to counsel newly diagnosed oncology patients on their fertility preservation options.
If a discrepancy is found, the pharmacy nurses will hold the shipment, and a clinical intervention will be communicated to the provider. The nurses complete a reassessment care plan prior to medications being shipped. During this time frame, the pharmacy documented 152 interventions.
SHOW MORE Steroids hindered the shrinkage of tumors in patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitor (ICI) therapy. The authors wrote that their findings could serve as a baseline for the steroids’ negative independent prognostic factor in patients with NSCLC undergoing ICI therapy.
These job duties each require different skill sets, from writing and verbal communication to process development, technical aptitude, and deep clinical expertise. And we need people to work side by side with prescribers to manage complex drug interactions, drug toxicities, and the financial implications of treatment selection.
I think it’ll be chemotherapy—maybe their cells being given outpatient—and then, as we hit their hardest time or their highest risk for either febrile neutropenia or mucositis or even some of the toxicities from the chemotherapy, we have them inpatient until we feel comfortable, and then transition it so that it could be all outpatient.
Mok : Right now, we have a lot of chemotherapy being used, but there are many more novel treatments being studied, especially in earlier lines of treatment. Bispecifics are moving up in the lymphoma space, and these newer therapies may have some synergistic effects with chemotherapy. REFERENCES 1.
The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat primary immunodeficiency (PI) in individuals aged two years and above. Credit: HenadziPechan/Shutterstock. Sign up for our daily news round-up!
It could be used for T-Cell Acute Lymphoblastic Leukaemia (T-ALL) treatment in patients for whom bone marrow transplantation and chemotherapy failed to work. CAR-T therapies are based on the patient’s immune cell modification and can express artificial chimeric receptors that can identify and remove tumour cells.
The antibody treatment was previously used as an additional layer of protection against the virus for those with compromised immune systems, such as those undergoing chemotherapy, or organ-transplant patients. read more
Traditionally, cancer patients are treated using “one size fits all” interventions like chemotherapy, radiotherapy and surgery. Visual communication. These tools not only make it easier to understand the service, but they can also help simplify communication and increase alignment between the many individuals engaged in the project.
Chemotherapy used to treat blood cancer results in increased intestinal permeability, making E. Subjects were dosed over seven days, and reportedly only experienced mild to moderate side effects with no withdrawals. coli a frequent cause of bloodstream infections that carries a 15-20% fatality rate.
Glues can be used to introduce or restore communication between pathways that prompt cell death, which tumor cells have typically adapted themselves to avoid. Kymera Therapeutics is working on protein degraders for a wide range of immune diseases, and some cancers. Kymera’s oral degrader KT-621, which targets STAT6, is a good example.
1 Every year, 19,500 people are diagnosed with lymphoma 2 – a cancer affecting a certain type of white blood cell within the immune system – and can be classed as either slow or fast growing. Now, people living with particular types of lymphoma have individualised options beyond chemotherapy for the first time.”.
The company is focused on its planned first-in-human trial designed for assessing DNase, along with immune checkpoint inhibitors or chemotherapy. The collaboration will also support the development of XCART, a DNase-armoured personalised chimeric antigen receptor (CAR) T cell technology for the treatment of B-Cell lymphomas.
Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation.
CALD is associated with six major functional disabilities (MFDs) which severely compromise the ability to function independently, including loss of communication, need for tube feeding and complete loss of voluntary movement. The two patients from ALD-102 who have not reached month 24 have also shown no evidence of MFDs.
Pharmacists can help in improving patients’ pain management understanding by assisting in mitigating the adverse effects of pain medications and by communicating efficiently with providers. Vaccinations can be given before, during, and after chemotherapy. Before chemotherapy, all indicated vaccines should be given to the patient.
Teaching - A selfless effort driven by passion Ideation - Dream big, start small Perspectives - How we viewed the world Work is Work - Do not take things too personal Knowledge is Not Free - The sad truth Communication - Food for thought Phone Addiction - Reflection on living Forget - Why I create notes?
There are also times when patients describe symptoms in their native language (such as Mandarin), adding another layer to communication challenge. Autism spectrum disorders 孤独症 (又称自闭症) - A complex developmental condition involving persistent challenges with social communication, restricted interests, and repetitive behaviour.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content